Leerink Partners

Leerink Partners

Pulse 2.0

Precision BioSciences (DTIL) Stock: Why It Surged Over 35% Today

Pulse 2.0

Arcus Biosciences (RCUS) Stock: Why The Price Jumped Up Today

Pulse 2.0

Kinnate Biopharma (KNTE) Stock: Why The Price Surged Today

Pulse 2.0

Avrobio (AVRO) Stock: Why The Price Fell Today

Pulse 2.0

TCR2 Therapeutics Stock (TCRR): $5 Price Target From Goldman Sachs

Pulse 2.0

Avrobio Stock (AVRO): Why The Price Substantially Fell

Pulse 2.0

Arcus Biosciences (RCUS) Stock: Why The Price Jumped Today

$98,000,000 Venture capital (Series C)
FinSMEs

Kinnate Biopharma Closes $98M Series C Financing

$30,000,000 Venture capital
FinSMEs , Pulse 2.0

Kyruus Raises $30M in Funding

Pulse 2.0

Gilead Sciences (GILD) Signs $2 Billion Deal With Arcus Biosciences (RCUS)

Xconomy

Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq

Xconomy

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

FinSMEs

Generation Bio Raises $110M in Series C Financing

$74,500,000 Venture capital (Series B)
Pulse 2.0 , FinSMEs

Precision Oncology Company Kinnate Biopharma Raises $74.5 Million

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With Arcus Biosciences Inc ...

$126,400,000 IPO
PE HUB

VC-backed BioSciences goes public

$80,000,000 Venture capital (Series B)
FinSMEs , MedCity News

Fulcrum Therapeutics Raises $80M in Series B Financing

Funding Health Science
$110,000,000 Venture capital (Series B)
FinSMEs

Precision BioSciences Raises $110M in Series B Funding

Funding
$99,700,000 IPO
PE HUB

VC-backed Avrobio rolls out IPO

Stock markets Health
$10,000,000 Venture capital
MedCity News

Health IT startup Kyruus brings in $10M to support matching patients with providers